EquityZen Growth Technology Fund LLC - Series 1747
Raised
$135K
Investors
10
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1747 is a Delaware-registered pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett, raising $135K from 10 investors with a $10K minimum investment under Regulation D Rule 506(b) and Section 3(c)(1). This is part of the EquityZen platform, which operates 1,889 related entities focused on pre-IPO secondary market access.
This pre-IPO fund follows the standard EquityZen series structure with a relatively low $10K minimum investment, making private company equity accessible to accredited investors. The 506(b) and 3(c)(1) exemption combination is typical for sub-100 investor pooled funds targeting specific secondary market opportunities.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
